Epignostix
ID: 17664294Epignostix is an AI-driven diagnostic tumor classifier founded in 2022.
2
Funding Rounds
$9.4m
Money raised
Recent Funding Rounds
Overview
Epignostix is an AI-driven diagnostic tumor classifier founded in 2022.
- Website:
- Business model: B2B
- Headquarters: Heidelberg
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding series
Funding Series Analysis
The company Epignostix has raised a total of $9.4m in funding over 2 rounds.
Key Insights:
- Epignostix July 2024 Seed Funding Round: $4.7m
- Epignostix July 2024 Seed Funding Round: $4.7m
Industries
Epignostix is active in the following industries: